Mirion Technologies MIR Medical — Adjusted Income Loss From Operations

Similar metrics at other companies

DOCOutpatient medical — Adjusted Net Operating Income From Continuing Operations

$198.38M+0.5%

MSA

MSAAmericas segment — Adjusted operating income from reportable segments

$98.13M+24.7%

BBYDomestic Segment — Adjusted Operating Income Loss

$358M+8.8%

BBYInternational Segment — Adjusted Operating Income Loss

$5M+25.0%

BBWIReportable Segment — Operating Income (Loss), Adjusted

$151M-27.8%

SAICCorporate Segment — Adjusted operating income (loss)

$7M+178%

FAQ

What is Mirion Technologies's medical — adjusted income loss from operations?

Mirion Technologies (MIR) reported medical — adjusted income loss from operations of -$26.5M in Q2 2026.

How has Mirion Technologies's medical — adjusted income loss from operations changed year-over-year?

Mirion Technologies's medical — adjusted income loss from operations increased by 10.5% year-over-year, from -$29.6M to -$26.5M.

What is the long-term trend for Mirion Technologies's medical — adjusted income loss from operations?

Over 3 years (2022 to 2025), Mirion Technologies's medical — adjusted income loss from operations has grown at a -0.2% compound annual growth rate (CAGR), from -$109.7M to -$109M.

What does medical — adjusted income loss from operations mean?

Measures the operating profitability of the Medical segment after excluding non-recurring or non-operational items such as restructuring costs, acquisition-related expenses, or stock-based compensation. This non-GAAP metric provides a clearer view of the segment's core operational efficiency and underlying earnings power. It is frequently used by management and investors to assess the segment's sustainable performance independent of accounting anomalies.